Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA

Kedudukan dalam Saham #35785
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Harga Saham
$0.016
Disegerakkan terakhir: 2024-03-11
Modal Pasaran
$3.27M
Perubahan (1 hari)
-5.33%
Perubahan (1 tahun)
5,233.33%
Negara
US
Perdagangan Invitae Corporation (NVTA)

Kategori

Healthcare
Nisbah P/S bagi Invitae Corporation (NVTA)
Nisbah P/S pada October 2026 TTM: 0.00
Menurut laporan kewangan dan harga saham terkini Invitae Corporation, nisbah P/S semasa (TTM) ialah 0.00. Pada akhir 2021, nisbah P/S syarikat ialah 7.00.
Sejarah nisbah P/S untuk Invitae Corporation dari 2012 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
2026 (TTM) 0.00 -99.98%
2022 0.85 -87.86%
2021 7.00 -65.24%
2020 20.13 197.75%
2019 6.76 35.23%
2018 5.00 -19.26%
2017 6.19 -41.13%
2016 10.52 -61.96%
2015 27.65 -91.27%
2014 316.76 -81.52%
2013 1.71K 0.00%
2012 0.00 0.00%
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
5.37 2,685,850.00%
US
6.29 3,145,950.00%
US
21.02 10,509,550.00%
US
- -
CN
6.67 3,333,000.00%
US